ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,254 | -35.6% | 9,053 | -14.6% | 0.00% | 0.0% |
| Q2 2023 | $377,853 | +55.9% | 10,596 | +11.1% | 0.00% | 0.0% |
| Q1 2023 | $242,341 | -48.8% | 9,541 | -18.2% | 0.00% | 0.0% |
| Q4 2022 | $473,295 | -20.6% | 11,669 | -35.3% | 0.00% | -50.0% |
| Q3 2022 | $596,000 | +25.5% | 18,043 | +34.0% | 0.00% | +100.0% |
| Q2 2022 | $475,000 | -54.9% | 13,468 | -41.2% | 0.00% | -50.0% |
| Q1 2022 | $1,053,000 | -17.3% | 22,906 | +19.2% | 0.00% | 0.0% |
| Q4 2021 | $1,274,000 | -9.6% | 19,217 | -14.9% | 0.00% | -33.3% |
| Q3 2021 | $1,410,000 | -78.0% | 22,590 | -70.8% | 0.00% | -75.0% |
| Q2 2021 | $6,406,000 | +27.9% | 77,347 | +2.4% | 0.01% | +20.0% |
| Q1 2021 | $5,009,000 | +22.0% | 75,528 | +41.1% | 0.01% | +25.0% |
| Q4 2020 | $4,106,000 | +414.5% | 53,510 | +188.6% | 0.01% | +300.0% |
| Q3 2020 | $798,000 | -47.3% | 18,539 | -47.1% | 0.00% | -50.0% |
| Q2 2020 | $1,513,000 | -73.0% | 35,030 | -82.0% | 0.00% | -75.0% |
| Q1 2020 | $5,602,000 | -71.2% | 194,708 | -36.5% | 0.02% | -62.8% |
| Q4 2019 | $19,446,000 | +510.5% | 306,575 | +171.3% | 0.04% | +437.5% |
| Q3 2019 | $3,185,000 | -6.2% | 113,023 | -11.8% | 0.01% | 0.0% |
| Q2 2019 | $3,397,000 | +17778.9% | 128,212 | +12052.8% | 0.01% | – |
| Q1 2019 | $19,000 | +137.5% | 1,055 | +52.0% | 0.00% | – |
| Q4 2018 | $8,000 | -99.6% | 694 | -99.4% | 0.00% | -100.0% |
| Q3 2018 | $2,247,000 | +486.7% | 117,200 | +316.4% | 0.01% | +400.0% |
| Q2 2018 | $383,000 | +5371.4% | 28,145 | +2897.3% | 0.00% | – |
| Q1 2018 | $7,000 | +250.0% | 939 | -23.7% | 0.00% | – |
| Q4 2016 | $2,000 | -66.7% | 1,231 | +59.2% | 0.00% | – |
| Q3 2016 | $6,000 | – | 773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |